Oral realgar in the treatment of patients with myelodysplastic syndrome

Abstract

Chinese arsenic drugs have been applied in Chinese medicine for several centuries. Active ingredients of realgar is As₂S₂. Oral realgar has been widely used in the treatment of myelodysplastic syndrome (MDS) with obvious Chinese characteristics, and the good clinical outcomes have been achieved. Decreasing the gastrointestinal adverse reactions of realgar can not only increase tolerance of patient to realgar, but improve the clinical efficacy, which will ensure the safety of oral realgar for clinical use, as well as open a new vision for the treatment of MDS.